These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25949086)

  • 1. Idiopathic Peripapillary Subretinal Neovascular Membrane in a Young Woman with Recurrence of the Lesion during Pregnancy after Treatment with Intravitreal Bevacizumab.
    Al-Gharbi N; Al Abdulsalam O; Al Habash A
    Middle East Afr J Ophthalmol; 2015; 22(2):245-8. PubMed ID: 25949086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.
    Davis AS; Folk JC; Russell SR; Sohn EH; Boldt HC; Stone EM; Mahajan VB
    Arch Ophthalmol; 2012 Aug; 130(8):1073-5. PubMed ID: 22893085
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R; Soliman W; Lund-Andersen H; Larsen M
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: Long-Term Visual and Anatomical Outcomes After Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Dʼsouza P; Ranjan R; Babu U; Kanakath AV; Saravanan VR
    Retina; 2018 Jul; 38(7):1307-1315. PubMed ID: 28520642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.
    Narayanan R; Shah VA
    Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subfoveal choroidal thickness in idiopathic choroidal neovascularization and treatment outcomes after intravitreal bevacizumab therapy.
    Kim H; Lee K; Lee CS; Byeon SH; Lee SC
    Retina; 2015 Mar; 35(3):481-6. PubMed ID: 25313710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen.
    Knape RM; Zavaleta EM; Clark CL; Khuddus N; Peden MC
    J AAPOS; 2011 Feb; 15(1):87-90. PubMed ID: 21397813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab for iatrogenic choroidal neovascular membrane following vitreoretinal surgery for retinal detachment.
    Appanraj R; Duraiswamy H; Saravanan V; Manayath G; Venkatapathy N
    Indian J Ophthalmol; 2020 Jun; 68(6):1201-1203. PubMed ID: 32461482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of peripapillary choroidal neovascularization with intravitreal bevacizumab.
    Hoeh AE; Schaal KB; Ach T; Dithmar S
    Eur J Ophthalmol; 2009; 19(1):163-5. PubMed ID: 19123169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial.
    Zhang H; Liu ZL; Sun P; Gu F
    Am J Ophthalmol; 2012 Feb; 153(2):300-306.e1. PubMed ID: 21982109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION: A Comparative Study.
    Sudhalkar A; Yogi R; Chhablani J
    Retina; 2015 Jul; 35(7):1368-74. PubMed ID: 25830696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.
    Ozgonul C; Moinuddin O; Munie M; Lee MS; Bhatti MT; Landau K; Van Stavern GP; Mackay DD; Lebas M; DeLott LB; Cornblath WT; Besirli CG
    J Neuroophthalmol; 2019 Dec; 39(4):451-457. PubMed ID: 30951011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Bevacizumab for Choroidal Neovascular Membrane at the Edge of a Healed Choroidal Tuberculoma.
    Tripathy K; Chawla R; Sharma YR
    Ocul Immunol Inflamm; 2018; 26(2):239-241. PubMed ID: 27541084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal aflibercept for choroidal neovascularization in ocular sarcoidosis.
    Querques L; Querques G; Miserocchi E; Modorati G; Bandello F
    Eur J Ophthalmol; 2016 Aug; 26(5):e124-7. PubMed ID: 26868005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
    Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
    Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB.
    Battaglia Parodi M; Iacono P; Bandello F
    Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MICROSTRUCTURAL EFFECTS OF INTRAVITREAL BEVACIZUMAB IN IDIOPATHIC CHOROIDAL NEOVASCULARISATION.
    Shah SN; Kang QY; Fan XJ; Shahbaz F
    J Ayub Med Coll Abbottabad; 2015; 27(2):259-63. PubMed ID: 26411092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
    Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
    Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro Re Nata Intravitreal Bevacizumab for the Treatment of Idiopathic Choroidal Neovascular Membrane.
    Saurabh K; Roy R; Panigrahi PK; Lobo A; Majumdar AK
    Semin Ophthalmol; 2016; 31(5):463-6. PubMed ID: 25392193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.